9,58 Tirzepatide has recently been evaluated in the SUMMIT trial
doi: 10.1007/s00392-020-01768-w 144 GabrielliOPuyAMDe RosaAArmandoIBarontiniMLevinG
Two new clinical trial results suggest this so-called "triple G" medication can deliver impressive weight loss and blood sugar results for people with excess weight who have heart disease or type 2 diabetes
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy
& OBrien, J
They lower blood glucose levels, slow gastric emptying, lower serum cholesterol and triglyceride levels, reduce liver fat content, decrease the highly inflammatory visceral fat, enhance microvascular (!) blood flows in the muscle tissue, reduce muscle-produced inflammation, microglial activation (neuroinflammation), and enhance neuroplasticity